Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05414396 · ClinicalTrials.gov registry record · NA
Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities
A NA study of Diabetes Mellitus and Obesity-Related Malignant Neoplasm, sponsored by City of Hope Medical Center.
- Active
- Registry status
- NA
- Development phase
- 347
- Enrollment target
- 1
- Study location
NCT05414396 is a NA study of Diabetes Mellitus and Obesity-Related Malignant Neoplasm that is active but no longer recruiting, run by City of Hope Medical Center. The registered enrollment target is 347 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05414396, a NA study of Diabetes Mellitus and Obesity-Related Malignant Neoplasm, is active but no longer recruiting, sponsored by City of Hope Medical Center.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 347 participants
- Enrollment target
- 1
- Study location
Study Summary
This clinical trial tests the Eat, Move, Live (EML) Program in reducing the risk of chronic diseases among underserved communities by improving healthy lifestyle practices, increasing physical activity and encouraging healthy eating behaviors. EML is a series of free culturally and linguistically appropriate nutrition and physical activity sessions. The interactive education segment of the EML Program is culturally responsive, and based on the community EML program, and topics will include: nutrition guidelines, reading food labels, recipe modification and healthy food preparation, eating healthy on a budget, chronic diseases information and prevention strategies. The EML program may help reduce the risk of cancer and chronic diseases by encouraging more physical activity and healthy eating behaviors.
Conditions Studied
Interventions
- OTHER Questionnaire Administration
- BEHAVIORAL Behavioral Intervention
Study Locations (1)
California
- City of Hope Medical Center - Duarte
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 347 participants |
| Start Date | 2018-03-20 |
| Est. Completion | 2026-10-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05414396
The ClinicalTrials.gov registry entry for NCT05414396 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 347 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (81% lower). The listed sponsor is City of Hope Medical Center, which has 582 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Diabetes Mellitus appearing as the primary indexed condition, and to 2 interventions - of which Questionnaire Administration is the first listed.
NCT05414396 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT05414396 about?
NCT05414396 is a clinical study titled "Eat, Move, Live Program for the Reduction of Cancer and Chronic Disease Risk in Underserved Communities". This clinical trial tests the Eat, Move, Live (EML) Program in reducing the risk of chronic diseases among underserved communities by improving healthy lifestyle practices, increasing physical activity and encouraging healthy eating behaviors. EML is a series of free culturally and linguistically ap...
What is the current status of trial NCT05414396?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 347 participants. The study started on 2018-03-20. Estimated completion is 2026-10-12.
What conditions does trial NCT05414396 study?
This clinical trial studies the following conditions: Diabetes Mellitus, Obesity-Related Malignant Neoplasm.
What interventions are being tested in trial NCT05414396?
The interventions under investigation include: Questionnaire Administration (OTHER), Behavioral Intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT05414396?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05414396 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Improving Glycemic Control With Telemedicine and Smart Insulin Pens
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Therapeutic Plantar Electrical Stimulation Intervention During Hemodialysis to Improve Balance and Mobility
RECRUITING · NA
-
FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing)
RECRUITING · NA
-
Innovative Multi-Variable Biofeedback for Improving Gait Performance in Individuals With Diabetic Peripheral Neuropathy
RECRUITING · NA
-
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.